Holen Sie sich die Stockscreener-App
0.3784
9.90%
-0.0416
Vorhandelsmarkt:
.38
0.0016
+0.42%
Schlusskurs vom Vortag:
$0.42
Offen:
$0.4049
24-Stunden-Volumen:
4.82M
Relative Volume:
1.71
Marktkapitalisierung:
$45.02M
Einnahmen:
$436.97M
Nettoeinkommen (Verlust:
$-35.62M
KGV:
-1.2685
EPS:
-0.2983
Netto-Cashflow:
$-10.71M
1W Leistung:
+23.30%
1M Leistung:
-10.27%
6M Leistung:
-64.96%
1J Leistung:
-76.05%
1-Tages-Spanne:
$0.36
$0.4296
1-Wochen-Bereich:
$0.3236
$0.44
52-Wochen-Spanne:
$0.25
$2.10
Accuray Inc Stock (ARAY) Company Profile
Firmenname
Accuray Inc
Sektor
Branche
Telefon
608-824-2800
Adresse
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
0.3784 | 49.96M | 436.97M | -35.62M | -10.71M | -0.2983 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-13 | Eingeleitet | ROTH MKM | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Loop Capital | Buy |
| 2020-01-21 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-11-01 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-12-13 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Eingeleitet | Lake Street | Buy |
| 2016-12-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Eingeleitet | Citigroup | Sell |
| 2015-05-01 | Bestätigt | Dougherty & Company | Buy |
| 2015-01-12 | Eingeleitet | Northland Capital | Outperform |
| 2014-01-31 | Bestätigt | Dougherty & Company | Buy |
| 2014-01-29 | Bestätigt | Brean Capital | Buy |
| 2013-11-11 | Bestätigt | Dougherty & Company | Buy |
| 2013-08-29 | Bestätigt | Dougherty & Company | Buy |
| 2011-09-20 | Bestätigt | Ticonderoga | Buy |
| 2010-02-08 | Hochstufung | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Hochstufung | UBS | Sell → Neutral |
| 2009-03-09 | Herabstufung | Soleil | Buy → Hold |
| 2009-01-30 | Hochstufung | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Bestätigt | Jefferies & Co | Hold |
| 2008-08-20 | Bestätigt | Jefferies & Co | Hold |
Alle ansehen
Accuray Inc Aktie (ARAY) Neueste Nachrichten
Accuray (NASDAQ: ARAY) grants SVP Paul Miele 650,000 restricted stock units - Stock Titan
Accuray Incorporated reports inducement award under Nasdaq Listing Rules - marketscreener.com
Accuray Incorporated Reports Inducement Award Under Nasdaq Listing Rules - TradingView
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules - Moomoo
Accuray(ARAY) Stock Options Chain | Quotes & News - Moomoo
ARAY - Finviz
TCW Group boosts Accuray (ARAY) stake to 13.7% through loan-linked warrants - Stock Titan
ARAY Stock Price, Quote & Chart | ACCURAY INC (NASDAQ:ARAY) - ChartMill
TCW Group (NASDAQ: ARAY) affiliates receive Accuray warrants tied to term loan - Stock Titan
Accuray brings AI in radiotherapy to ESTRO stage focusing on clinical performance and ethics - Traders Union
Accuray showcases Radixact system for paediatric radiotherapy at ESTRO conference - Traders Union
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Accuray and University of Wisconsin launch 10-year deal to advance personalized cancer radiation therapy. - Pluang
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer - PR Newswire
Accuray partners with University of Wisconsin on cancer research By Investing.com - Investing.com Canada
Accuray Company Profile & Introduction - Moomoo
News Flash: 2 Analysts Think Accuray Incorporated (NASDAQ:ARAY) Earnings Are Under Threat - Moomoo
Accuray Shares Fall After Jefferies Downgrade - Moomoo
Accuray Inc (ARAY) Runs Into Middle East Headwinds, But Shift Plan Is Working - Insider Monkey
Accuray, Aevex, Zoetis - TradingView
Jefferies Downgrades Accuray(ARAY.US) to Hold Rating, Cuts Target Price to $0.35 - 富途牛牛
Jefferies Downgrades Accuray to Hold From Buy, Adjusts Price Target to $0.35 From $3.50 - marketscreener.com
Jefferies downgrades Accuray stock rating on guidance withdrawal - Investing.com UK
Jefferies downgrades Accuray stock rating on guidance withdrawal By Investing.com - Investing.com South Africa
Accuray Slides As Insider Purchases Lose Another US$95k - Yahoo Finance
Accuray (ARAY) Q3 2026 Earnings Transcript - AOL.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Sahm
ARAY Reports Q3 Revenue Decline Amid Strategic Advancements - GuruFocus
ARAY Downgraded by BTIG -- Rating Changed to Neutral - GuruFocus
Accuray Incorporated (NASDAQ:ARAY) Q3 2026 Earnings Call Transcript - Insider Monkey
Accuray Q3 FY26 slides: guidance withdrawn amid geopolitical turmoil By Investing.com - Investing.com Canada
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026 - Investing News Network
BTIG downgrades Accuray stock rating on revenue challenges and guidance withdrawal - Investing.com Canada
BTIG Downgrades Accuray(ARAY.US) to Hold Rating - Moomoo
Accuray: Fiscal Q3 Earnings Snapshot - theheraldreview.com
Accuray Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Accuray Q3 Earnings Call Highlights - Yahoo Finance
Accuray IncWithdraws FY2026 Financial Guid - Moomoo
Earnings call transcript: Accuray’s Q3 2026 results miss forecasts, shares drop - Investing.com
Accuray Inc (NASDAQ:ARAY) Plunges 12.5% After Fiscal Q3 Earnings Miss - ChartMill
Accuray Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 - marketscreener.com
Rising interest, restructuring deepen Accuray (NASDAQ: ARAY) losses and add covenant risk - Stock Titan
[8-K] ACCURAY INC Reports Material Event - Stock Titan
Accuray Reports Fiscal 2026 Third Quarter Financial Results - ChartMill
Accuray Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
MSN Money - MSN
Earnings Preview: Accuray to Report Financial Results Post-market on May 06 - Moomoo
Accuray Incorporated Files Form 8-K Report with SEC Detailing Company Information and Compliance Data - Minichart
Finanzdaten der Accuray Inc-Aktie (ARAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):